Differential Expression of Claudin 1 and 4 in Basal Cell Carcinoma of the Skin

Table 2

Clinicopathological features and IHC scores of claudin 1 and 4 in basal cell carcinoma.

Case nos.	Age	Gender	Histological sybtype	Immunohistochemical score		Prognosis (follow-up, month)
				Claudin 1	Claudin 4
1	90	M	Micronodular	1+	2+	AWOR (8)
2	76	M	Infiltrating	3+	0	AWOR (13)
3	88	F	Nodular	3+	1+	AWOR (18)
4	69	F	Nodular	3+	1+	AWOR (10)
5	80	M	Nodular	3+	1+	AWOR (5)
6	73	F	Nodular	3+	1+	AWOR (60)
7	61	M	Nodular	3+	1+	AWOR (2)
8	71	F	Nodular	3+	0	AWOR (12)
9	78	M	Nodular	3+	0	AWOR (12)
10	81	F	Nodular	3+	0	AWOR (2)
11	57	F	Nodular	3+	0	AWOR (14)
12	85	F	Nodular	3+	0	AWOR (10)
13	57	M	Nodular	3+	0	AWOR (13)
14	60	M	Nodular	3+	0	AWOR (20)
15	77	F	Nodular	3+	0	AWOR (21)
16	89	M	Nodular	3+	0	AWOR (6)
17	74	F	Nodular	3+	0	AWOR (43)
18	82	M	Nodular	2+	1+	AWOR (6)
19	84	F	Nodular	2+	1+	AWOR (18)
20	46	M	Nodular	2+	1+	AWOR (2)
21	79	M	Nodular	2+	1+	AWOR (11)
22	82	M	Nodular	2+	0	AWOR (12)
23	48	M	Nodular	2+	0	AWOR (1)
24	79	F	Nodular	2+	0	AWOR (16)
25	70	F	Nodular	1+	0	AWOR (15)
28	80	M	Superficial	3+	1+	AWOR (12)
26	75	F	Superficial	3+	0	AWOR (6)
27	77	F	Superficial	3+	0	AWOR (6)
30	54	F	Superficial	3+	0	AWOR (20)
32	51	F	Superficial	3+	0	AWOR (8)
33	87	F	Superficial	3+	0	AWOR (22)
29	74	F	Superficial	2+	0	AWOR (3)
31	74	F	Superficial	2+	0	AWOR (4)
34	63	M	Infundibulocystic	2+	1+	AWOR (1)
35	43	F	Infundibulocystic	2+	1+	AWOR (17)
36	47	F	Fibroepithelial	3+	1+	AWOR (12)

F: female; M: male; AWOR: alive without recurrence.